datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

“…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”

datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

“…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”

Changes in TCC and some selected clinical and laboratory variables. by Thao H. P. Nguyen (11027765)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Changes in genitourinary symptoms after 4 weeks. by Remi Yoshikata (11419275)

Subjects:

Percentages (%) of concentration changes of cytokines for CD8+ T-cells after cultured in HCM or NCM of PANC-1 cells. by Eiman Abdo (20642254)

Subjects:

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Changes in tumor volume and DCE parameters. by Bo Kyu Kim (18501276)

Subjects:

Changes in ocular stress after wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

Subjects:

The animation of tension changes after wearing orthokeratology lenses. by Zhao-Yang Meng (18389630)

Subjects:

Change in the number of Iba-1-positive cells in the dorsal root ganglia (DRG) of PSNL-exposed rats and the effect of treatment with MSCs. by Kanako Miyano (3805288)

Subjects:

Integrin expression decreased in treated tumors. by Anthony B. Eason (6294305)

Multilevel regression models of anxiety over the course of clinical treatment. by David H. Rosmarin (16542340)

Subjects:

Changes in maximal strength within each group after treatment. by Sergio R. Thomaz (20308465)

Scatter dot plot of the absolute levels of change in LH and FSH between the baseline and week-15 visit. by Sigrid Nilsson (12647302)

Subjects:

Change in lateral distribution of COD concentration and flow velocity with and without piers. by Haibin Xiong (11778010)

Subjects:

Proportions of intervals where cytokines change varies between cytokines. by Jordan K. Abbott (8934239)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects: